Journal News

Common blood protein isoforms show promise for Alzheimer’s testing

Leia Dwyer
March 30, 2021

Apolipoproteins are amphipathic proteins, meaning they both absorb and repel water. Therefore, they can transport lipids and fat-soluble vitamins through the body's water-based circulatory system. While apolipoproteins have been well studied in the blood, researchers focus less on them in the cerebrospinal fluid, or CSF, despite their role in transporting lipids to regulate lipid metabolism in the brain. Dysfunctional lipid metabolism in the brain is implicated in neurodegenerative conditions such as Alzheimer's disease.

Dobrin Nedelkov, president and founder of Isoformix, works with Yueming Hu to develop next-generation mass spectrometry clinical tests to differentiate isoforms of proteins that may have clinical significance in human disease. Standard clinical assays cannot detect these differences. In a recent paper in the Journal of Lipid Research, Nedelkov, Hu and collaborators compared truncated and glycosylated isoforms of three apolipoproteins in plasma and CSF samples.

Nedelkov and Hussein Yassine, a researcher at the University of Southern California, have a long-standing collaboration studying lipoproteins and a friendship born from years of shared research. "We are both determined and curious, and we are not afraid to try new things together," Nedelkov said. "It's easier to find reasons why not to do it than to do it."

Previously, they have studied lipoproteins in plasma from patients with diabetes and cardiovascular disease. In this study, Nedelkov was excited to expand their collaboration to another area of Yassine's research: Alzheimer's disease, for which no diagnostic test exists. "We always wanted to work with Alzheimer's disease, but there was no easy access for us to get samples," Nedelkov said.

Alzheimers-testing-890x473.jpg
Ajpolino/Wikimedia Commons
A structural model of the 22k fragment of apolipoprotein E4.

A set of matched plasma and CSF samples from 61 healthy patients without clinical Alzheimer's disease from the USC Alzheimer Disease Research Center presented a rare opportunity to study how protein isoforms correlate between the blood and brain. CSF samples are harder to obtain, as patients must undergo a lumbar puncture, which is more invasive and time-consuming than blood sampling.

Few researchers have studied apolipoproteins in the CSF. "When we started looking, we didn't even know what we were going to find out," Nedelkov said.

The team found a significantly higher percentage of the truncated protein isoforms of two apolipoproteins, apoC-I and apoC-II, in the CSF compared to blood, as well as a higher percentage of the glycosylated forms of a third, apoC-III. In each of these findings, the changes in CSF protein isoforms correlated with measured changes in the plasma samples, suggesting plasma sampling could help researchers better understand processes in the brain.

The researchers also compared the apoE ε4 allele status of the donors with those increased apolipoprotein isoforms. This allele is one of the strongest available genetic predictors of Alzheimer's, and they found differences in the isoform profiles in individuals carrying the allele, suggesting an association between Alzheimer's and apoC processing and function in the brain, which might someday be used to predict disease risk.

Nedelkov hopes the results of the team's work in Alzheimer's will help overcome challenges to adopting mass spectrometry protein tests in clinical labs due to cost and complexity. The ability to distinguish protein isoforms and the relationship between these biomarkers in plasma versus CSF could open the door to minimally invasive clinical tests. Nedelkov and Yassine plan to apply their findings in a study of samples from a larger cohort of 200 to 300 patients with varying stages of Alzheimer's.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Leia Dwyer

Leia Dwyer is a Boston-area biotech and pharmaceutical industry professional.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Computational tool helps scientists create novel bug sprays
Journal News

Computational tool helps scientists create novel bug sprays

May 20, 2025

Rapid discovery of mosquito repellent compounds is enabled through a novel screening platform that combines both computational modeling and functional screening.

Meet Lan Huang
Interview

Meet Lan Huang

May 19, 2025

Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Influenza gets help from gum disease bacteria
Journal News

Influenza gets help from gum disease bacteria

May 15, 2025

Scientists discover that a protease from Porphyromonas gingivalis enhances viral spread. Read more about this recent Journal of Biological Chemistry paper.

How bacteria fight back against promising antimicrobial peptide
Journal News

How bacteria fight back against promising antimicrobial peptide

May 15, 2025

Researchers find a mutation in E. coli that reduces its susceptibility to a potential novel antibiotic. Read more about this recent Journal of Biological Chemistry paper.

New clues reveal how cells respond to stress
Journal News

New clues reveal how cells respond to stress

May 15, 2025

Redox signaling protein may help regulate inflammasome and innate immune activation. Read more about this recent Journal of Biological Chemistry paper.

Innovative platform empowers scientists to transform venoms into therapeutics
Journal News

Innovative platform empowers scientists to transform venoms into therapeutics

May 13, 2025

Scientists combine phage display and a “metavenome” library to discover new drugs that bind clinically relevant human cell receptors. Read about this recent Molecular & Cellular Proteomics paper.